justbacked

Biotechnology, Health Care, Life Science, Medical, Therapeutics

ai3Bio

ai3Bio raised $48M in a Series A announced on Sep 29, 2026, led by Ziff Capital Partners, UPMC Enterprises, Tanis ventures, Cockrell Interests. Since then it has posted 2 roles (1 still open), the first 7 days after it. With 1 open roles it is hiring more than 0% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $103M over 2 rounds from 1 investors.

Roles posted per month since the round
  • October 20261
  • November 20261

From ai3Bio's own hiring system, by posting date. Tracked since Oct 6, 2026; roles that closed before then aren't counted.

ai3Bio develops treatments to transform the lives of patients with cancer.

Why join ai3Bio?

This could be huge if one treatment that removes disease-causing T cells becomes the autoimmune standard, replacing drugs that suppress the whole immune system. ai3Bio, a Pittsburgh biotech, has two platforms aimed at the same pathogenic T cells, one an mRNA nanoparticle and one a targeting antibody. Its $48M Series A in late September, led by Ziff Capital Partners and UPMC Enterprises, lifts the total to $103M across two rounds.

JustBacked's take, based on ai3Bio's own site and its funding and hiring data.

Series A · $48M · 53d agoai3.bio

Hiring velocity

Open roles
1
Added, 30 days
+1
Added, 7 days
+0
Closed, 30 days
1
Raised
53 days ago
Led by
Ziff Capital Partners, UPMC Enterprises, Tanis ventures, Cockrell Interests
Team size
11-50
HQ
Pittsburgh, Pennsylvania, United States
Newest role
17d ago
Tracked since
Oct 6, 2026

Open roles at ai3Bio

Source: cornertx.bamboohr.com, checked daily.